Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 8:44 pm Sale | 2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | Venrock Healthcare Capital Partners III, L.P. | 10,412,872 5.600% | -4,031,572 (-27.91%) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RA CAPITAL MANAGEMENT L.P. | 18,670,089 9.990% | -20,779 (-0.11%) | Filing History |
| 2024-02-14 07:08 am Purchase | 2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW Investments, LP | 18,505,556 9.800% | 18,505,556 (New Position) | Filing History |
| 2024-02-09 4:24 pm Sale | 2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | TCG Crossover GP I, LLC | 2,912,861 1.600% | -8,198,250 (-73.78%) | Filing History |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 22,439,124 12.002% | -5,534,422 (-19.78%) | Filing History |
| 2023-09-11 08:23 am Purchase | 2023-09-08 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 27,973,546 14.962% | 24,768,624 (+772.83%) | Filing History |
| 2023-08-28 4:16 pm Purchase | 2023-08-16 | 13G | Taysha Gene Therapies, Inc. TSHA | Venrock Healthcare Capital Partners III, L.P. | 14,444,444 7.700% | 14,444,444 (New Position) | Filing History |
| 2023-08-25 5:01 pm Purchase | 2023-08-16 | 13G | Taysha Gene Therapies, Inc. TSHA | RA CAPITAL MANAGEMENT L.P. | 18,690,868 9.990% | 18,690,868 (New Position) | Filing History |
| 2023-08-25 4:22 pm Purchase | 2023-08-16 | 13G | Taysha Gene Therapies, Inc. TSHA | TCG Crossover GP I, LLC | 11,111,111 5.900% | 11,111,111 (New Position) | Filing History |
| 2023-08-21 4:01 pm Purchase | 2023-08-16 | 13D | Taysha Gene Therapies, Inc. TSHA | Paul B Manning | 23,476,333 12.600% | 16,486,472 (+235.86%) | Filing History |
| 2023-08-18 5:16 pm Purchase | 2023-08-16 | 13D | Taysha Gene Therapies, Inc. TSHA | Astellas Pharma Inc. | 7,266,342 3.890% | 7,266,342 (New Position) | Filing History |
| 2023-02-09 12:39 pm Sale | 2023-02-09 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 3,204,922 5.132% | -69,635 (-2.13%) | Filing History |
| 2022-11-10 11:55 am Sale | 2022-11-09 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 3,274,557 5.951% | -1,005,937 (-23.50%) | Filing History |
| 2022-11-02 4:02 pm Purchase | 2022-10-31 | 13D | Taysha Gene Therapies, Inc. TSHA | Paul B Manning | 6,989,861 11.200% | 1,694,554 (+32.00%) | Filing History |
| 2022-10-31 4:02 pm Purchase | 2022-10-21 | 13D | Taysha Gene Therapies, Inc. TSHA | Audentes Therapeutics Inc. BOLD | 7,266,342 11.600% | 7,266,342 (New Position) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | Taysha Gene Therapies, Inc. TSHA | BlackRock Inc. BLK | 1,046,490 2.600% | -1,986,473 (-65.50%) | Filing History |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 4,280,494 11.125% | -1,383,721 (-24.43%) | Filing History |
| 2022-02-07 4:41 pm Purchase | 2021-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | BlackRock Inc. BLK | 3,032,963 7.900% | 803,147 (+36.02%) | Filing History |
| 2021-09-23 6:56 pm Sale | 2021-09-22 | 13G | Taysha Gene Therapies, Inc. TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,156,255 3.010% | -1,022,745 (-46.94%) | Filing History |
| 2021-02-16 1:35 pm Purchase | 2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,179,000 5.770% | 2,179,000 (New Position) | Filing History |